Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Mediland Pharm (MPH) has partnered with five Sydney-based pharmacies to distribute the company’s health and well-being products
  • Mediland-branded products will now be stocked by Market City Pharmacy, Haymarket Pharmacy, Pavilion Pharmacy Town Hall, and Sydney City Pharmacy
  • Alongside this news, the company has made its Mediland app available on both Apple and Android devices in an effort to spur online sales
  • And in an effort to preserve cash during the COVID-19 pandemic, the company has reduced rental expenses and has frozen all fees for its non-executive directors
  • Mediland Pharm shares are steady today, trading for 13 cents each

Health and wellness retailer Mediland Pharm (MPH) has partnered with five Sydney-based pharmacies to distribute the company’s products. 

As well as health and wellness products, the company sells cosmetics, jewellery and wool. Mediland currently operates three retail stores located in Australia and another in New Zealand, catering largely to the tourism market. 

The company’s Mediland-branded products will now be stocked by Market City Pharmacy, Haymarket Pharmacy, Pavilion Pharmacy Town Hall, and Sydney City Pharmacy. 

The new distributors will stock a range of Mediland wellness products including Glucosamine, Bio-Squalene, Eye Excel, Respiraclear.  

The news comes after Mediland announced a similar agreement with Priceline Clemton Park earlier this year.

Alongside this news, the company announced it’s intensifying its focus on the online retail sector. Online commerce has recently seen a boost in traffic, as pandemic-related quarantine restrictions drive consumers online. 

Consequently, the company has made its Mediland App available on both Apple and Android devices in an effort to spur online sales further. 

Chairman of Mediland, Peter French, is pleased with the company’s progress in expanding its income streams.

“Securing five Sydney-based retail pharmacies to stock and sell our increasing range of health and well-being products indicates the potential to expand further in this channel,” Peter said.

“We are particularly pleased to see the rewards of our commitment over the past year to implement and grow our e-commerce platform. The company aims to continue to expand and further diversify our revenues whilst reducing costs where possible to offset the challenges from the COVID-19 pandemic,” he continued.

In an effort to preserve cash during the pandemic, the company has reduced rental expenses and has frozen all fees for its non-executive directors. 

Mediland Pharm shares are steady today, trading for 13 cents each at 11:52 am AEST.

MPH by the numbers
More From The Market Herald
Incannex Healthcare (ASX:IHL)

" Incannex Healthcare (ASX:IHL) engages Procaps to manufacture sleep apnoea treatment

Incannex Healthcare (IHL) has engaged a company to manufacture its soft-gel capsules in preparation for upcoming clinical trials.
(ASX:ATH) -

" Alterity Therapeutics (ASX:ATH) expands clinical development program

Alterity Therapeutics (ATH) is expanding the phase two clinical development program for its lead asset ATH434 in patients with Multiple System Atrophy (MSA).
Althea Group (ASX:AGH) - CEO, Joshua Fegan

" Althea Group (ASX:AGH) hits new high in sales receipts

Althea Group (AGH) brought in a new high of $4.5 million in customer receipts over the recently completed September quarter.
Singular Health Group (ASX:SHG) - Chief Operating Officer, James Hill

" Singular Health (ASX:SHG) collaborates with CSIRO and Osteopore (ASX:OSX)

Singular Health Group (SHG) will collaborate with CSIRO and Osteopore (OSX) for an artificial intelligence (AI) based tool to make patient-specific 3D cranial